Newsletters and Deep Dive digital magazine
Katalin Karikó and Drew Weissman of the University of Pennsylvania have jointly won the 2023 Nobel Prize in Physiology or Medicine for discoveries that enabled the develop
To improve trial recruitment, engagement, and retention, and to increase the likelihood that trials reflect what matters most to patients, regulatory authorities increasingly point to metho
To continue delivering high-quality and patient-centred care, the future oncology workforce of the NHS needs to be agile, expansive, and diverse.
It’s about that time of year when many global teams turn their attention towards annual strategic planning.
Coaching has developed into one of the most powerful tools in a fast-changing pharmaceutical sector.
Life with a rare condition can have a significant impact – and often cause unmendable strain – on close relationships, from family members to friends to romantic partners.
CRISPR-based therapies are undergoing a remarkable evolution, with drug developers striving to enhance the safety, precision and efficacy of their products.
Get in-depth news, opinions and features on pharma and healthcare sent straight to your inbox
Problems at a contract manufacturing organisation have scuppered Eli Lilly’s hopes of a timely FDA approval for lebrikizumab, its IL-13 inhibitor for the treatment of atop
Drug discovery is usually a goal-driven and iterative process, as researchers look for innovative new routes to target particular diseases and study those diseases in afflicted patients to learn ho